Joseph Vittiglio's most recent trade in Bluebird bio Inc was a trade of 238 Common Stock done at an average price of $7.4 . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bluebird bio Inc | Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 03 Feb 2025 | 238 | 4,501 (0%) | 0% | 7.4 | 1,759 | Common Stock |
| Bluebird bio Inc | Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 94,783 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 05 Feb 2024 | 5,217 | 44,783 (0%) | 0% | 0.9 | 4,708 | Common Stock |
| Finch Therapeutics Group Inc | Joseph Vittiglio | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 21 Oct 2022 | 3,636 | 31,364 | - | 1.4 | 5,054 | Common Stock |
| Finch Therapeutics Group Inc | Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Finch Therapeutics Group Inc | Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Finch Therapeutics Group Inc | Joseph Vittiglio | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Finch Therapeutics Group Inc | Joseph Vittiglio | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 60,578 | 60,578 | - | - | Employee Stock Option (right to buy) | |
| Finch Therapeutics Group Inc | Joseph Vittiglio | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 34,616 | 34,616 | - | - | Employee Stock Option (right to buy) |